1. Introduction {#sec1}
===============

Best macular dystrophy describes a relatively uncommon autosomal dominant retinal disorder with an estimated prevalence of 1.5--20 cases per 100,000 individuals.[@bib1]^,^[@bib2] It is characterized by vitelliform lesions of the central maculae that often develop retinal pigment epithelium (RPE) hyperpigmentation and atrophy over time. While extramacular vitelliform lesions can occur in a multifocal variant of Best dystrophy, other non-macular retinal lesions have not been associated with this genotype. Here, we report a case of an adolescent male with Best macular dystrophy who also developed a solitary retinal astrocytic hamartoma. This report was carried out with approval from the Institutional Review Board (IRB) at the Oregon Health & Science University, is Health Insurance Portability and Accountability Act (HIPAA) compliant, and the patient and his family provided written consent for publication.

2. Case {#sec2}
=======

A 6 year old male with a history of amblyopia in the left eye initially presented to our eye clinic in 2009 for evaluation of vitelliform lesions in both maculae. Genetic testing revealed a previously described disease-causing mutation in *BEST1*, namely Tyr227Cys (EPP = 3).[@bib3]^,^[@bib4] Examination of family members concluded the father was a Best non-penetrant gene carrier. The patient has since been followed routinely for hereditary Best macular dystrophy and, while the macular sub-retinal pigment epithelium (RPE) deposits have slowly progressed, the patient has maintained a best corrected visual acuity of 20/20 and 20/25 in the right and left eyes, respectively.

Beginning in 2013, a peripapillary white and patchy superficial retinal lesion began to be noted superonasal to the optic nerve. Over the ensuing four years, it was noted to slowly increase in size, and the peripheral retina developed a tapetal sheen ([Fig. 1](#fig1){ref-type="fig"}). Optical Coherence Tomography (OCT) of the lesion in 2018 demonstrated a hyperreflective thickening of the inner retinal layers with a moth-eaten appearance and posterior shadowing ([Fig. 2](#fig2){ref-type="fig"}A--B). Fluorescein angiography showed early filling of the small lacey vessels within the lesion ([Fig. 2](#fig2){ref-type="fig"}C) with pronounced residual hyperfluoresence in the late phases, and no defined feeder vessel. OCT angiography showed vascular flow consistent with a disorganized capillary network within the lesion, which recapitulates the findings on fluorescein angiography ([Fig. 2](#fig2){ref-type="fig"}D). Combined with the ophthalmoscopic appearance, multimodal imaging of the lesion was consistent with a retinal astrocytic hamartoma.[@bib5], [@bib6], [@bib7]Fig. 1Fundus photography of the patient at 15 years old. **(Top)** Right eye color fundus photo showing a macular scrambled vitelliform lesion, a nasal peripapillary white and patchy superficial retinal lesion, and tapetal sheen with multiple mid-peripheral hyper-pigmented patches. Left eye showing similar findings, but without a peripapillary lesion. **(Bottom/Inset)** Magnified view of the peripapillary lesion with longitudinal images documenting the growth of the lesion over the past 5 years. There is a small inferior vitelliform deposit that developed one year ago.Fig. 1Fig. 2**(A)** Infrared image of the optic nerve and nasal peripapillary lesion with a horizontal line indicating the plane of the displayed OCT image. **(B)**Thickening of the nerve fiber layer on SD-OCT, with mass-effect and scattered pinpoint optically empty spaces within the lesion. **(C)** Fluorescein angiography showing early filling of the small vasculature within the lesion. **(D)** OCT angiography demonstrating intralesional vascular flow of small vessels, as well as blocking of the underlying retinal vasculature by the lesion.Fig. 2

To assess for a potential underlying genetic syndrome associated with the astrocytic hamartoma, the patient was referred to medical genetics where a systemic work-up was performed. Family history was negative for any phakomatoses. No pathognomonic cutaneous findings of tuberous sclerosis complex or neurofibromatosis type 2 were found on physical exam. There were two café-au-lait macules 1 cm in size, one on each hip, which were too few in number to be of diagnostic value. Molecular testing for *TSC1* and *TSC2* was negative. As there were no extraocular signs or symptoms that were diagnostic of a phakomatosis and negative genetic screening, MRI brain and abdomen were suggested, but not yet recommended at this time by medical genetics. He is currently being observed by ophthalmic and medical genetics on an annual basis.

3. Discussion {#sec3}
=============

Astrocytic retinal hamartomas represent a rare retinal condition and are usually associated with phakomatoses, with 71% percent of lesions in one series being associated with tuberous sclerosis or neurofibromatosis.[@bib8] Retinal astrocytic hamartomas have rarely been associated with inherited retinal degenerations (e.g. retinitis pigmentosa and Leber\'s congenital amaurosis),[@bib9]^,^[@bib10] and its association with Best disease in our case is highly unusual. Only one case of an 11 year old with a combined clinical diagnosis of both Best disease and tuberous sclerosis complex was recently reported.[@bib11] In contrast, our patient had no extraocular stigmata of tuberous sclerosis complex or neurofibromatosis 2, however symptoms may not manifest until later in life. Given the solitary and peripapillary nature of the astrocytic lesion in our patient, it may also be possible that this is a sporadic lesion that is not associated with a phakomatosis.[@bib8]^,^[@bib12] This case illustrates the need to proceed with a balanced approach when working-up patients potentially presenting with unusual combinations of inherited disorders.

4. Conclusion {#sec4}
=============

Retinal astrocytic hamartomas have previously been documented in patients with retinal dystrophies, including retinitis pigmentosa and Leber\'s congenital amourosis. Here, we present a rare case of a retinal astrocytic hamartoma in a child with Best macular dystrophy.

Patient consent {#sec5}
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Consent to publish this case report has been obtained from the patients legal guardian in writing.
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